在B级区生产吸入剂。FDA视吸入剂为无菌制剂。
To ensure patient safety, the FDA requires that drug products delivered via these routes be supplied as sterile products. This designation includes many complex drug products, including ophthalmic suspensions, sterile injectables, lyophilized powders for injection, and aqueous-based aerosols for inhalation.